Terumo Announces Change of Executive Officers

TOKYO, JAPAN — February 6, 2020 — Terumo Corporation (TSE: 4543) hereby announces that it has resolved a change of its Executive Officers as follows.

1. Change of Executive Officers (As of April 1, 2020)

Name	New Title	Current Title
Hikaru Samejima	Managing Executive Officer President, General Hospital Company Division President, Hospital Systems Division, General Hospital Company	Managing Executive Officer President, Cardiac and Vascular Company Division President, Interventional Systems Division, Cardiac and Vascular Company
Toshihiko Osada	Managing Executive Officer President, Cardiac and Vascular Company Division President, Interventional Systems Division, Cardiac and Vascular Company	Senior Executive Officer General Manager, Strategic Planning Dept.
Itaru Sakaguchi	Senior Executive Officer Chief Operations Officer (COO), Interventional Systems Division, Cardiac and Vascular Company	Executive Officer Chief Operations Officer (COO), Interventional Systems Division, Cardiac and Vascular Company
Hiroshi Nagumo	Executive Officer President and CEO, Terumo Americas Holding, Inc. Regional Representative, Latin America	Executive Officer Senior Vice President, Blood Center Solutions, Terumo BCT Holding Corp. President and Representative Director, Terumo BCT Japan, Inc. Production Dept. (Terumo BCT)
Fumihisa Hirose	Executive Officer General Manager, Strategic Planning Dept.	Executive Officer Senior Vice President, Cardiac and Vascular Company Senior Vice President, ME R&D, Cardiac and Vascular Company
Kenichi Ikeda	Executive Officer General Manager, Sales Promotion (Japan), Hospital Systems Division, General Hospital Company	Branch Manager, Osaka Branch, General Hospital Company
Kazunobu Handa	Executive Officer General Manager, Corporate Affairs Dept.	General Manager, Corporate Affairs Dept.
Toshio Nakashima	Executive Officer Chief Quality Officer (CQO) General Manager, Quality Assurance Dept. Post-Market Surveillance and Vigilance Dept.	General Manager, Quality Assurance Dept.
Takeshi Kuroo	Executive Officer Senior Vice President, Surgical Business, Cardiac and Vascular Company General Manager, HeartSheet Business Dept., Cardiac and Vascular Company	Factory Manager, Ashitaka Factory, Cardiac and Vascular Company
Robert DeRyke	Executive Officer Division President, Cardiovascular Division, Cardiac and Vascular Company President and CEO, Terumo Cardiovascular Systems Corp.	Division President, Cardiovascular Division, Cardiac and Vascular Company President and CEO, Terumo Cardiovascular Systems Corp.

About Terumo
Terumo (TSE:4543) is a global leader in medical technology and has been committed to "Contributing to Society through Healthcare" for nearly 100 years. Based in Tokyo and operating globally, Terumo employs more than 25,000 associates worldwide, to provide innovative medical solutions in more than 160 countries and regions. The company started as a Japanese thermometer manufacturer, and has been bolstering healthcare ever since. Now, its extensive business portfolio ranges from vascular intervention and cardio-surgical solutions, blood transfusion and cell therapy technology, to medical products essential for daily clinical practice. Terumo will further strive to be of value to patients, medical professionals, and society at large.